Oocyte quality is enhanced by hypoglycosylated FSH through increased cell-to-cell interaction during mouse follicle development

Development. 2023 Nov 15;150(22):dev202170. doi: 10.1242/dev.202170. Epub 2023 Nov 10.

Abstract

Macroheterogeneity in follicle-stimulating hormone (FSH) β-subunit N-glycosylation results in distinct FSH glycoforms. Hypoglycosylated FSH21 is the abundant and more bioactive form in pituitaries of females under 35 years of age, whereas fully glycosylated FSH24 is less bioactive and increases with age. To investigate whether the shift in FSH glycoform abundance contributes to the age-dependent decline in oocyte quality, the direct effects of FSH glycoforms on folliculogenesis and oocyte quality were determined using an encapsulated in vitro mouse follicle growth system. Long-term culture (10-12 days) with FSH21 (10 ng/ml) enhanced follicle growth, estradiol secretion and oocyte quality compared with FSH24 (10 ng/ml) treatment. FSH21 enhanced establishment of transzonal projections, gap junctions and cell-to-cell communication within 24 h in culture. Transient inhibition of FSH21-mediated bidirectional communication abrogated the positive effects of FSH21 on follicle growth, estradiol secretion and oocyte quality. Our data indicate that FSH21 promotes folliculogenesis and oocyte quality in vitro by increasing cell-to-cell communication early in folliculogenesis, and that the shift in in vivo abundance from FSH21 to FSH24 with reproductive aging may contribute to the age-dependent decline in oocyte quality.

Keywords: FSH glycoform; Mouse; Oocyte quality; Ovarian follicle; Transzonal projections.

MeSH terms

  • Animals
  • Cell Communication
  • Estradiol / pharmacology
  • Female
  • Follicle Stimulating Hormone* / pharmacology
  • Follicle Stimulating Hormone* / physiology
  • Mice
  • Oocytes*
  • Ovarian Follicle

Substances

  • Follicle Stimulating Hormone
  • Estradiol